Market Access Why the Novo Nordisk Foundation is betting big on stem cells One area where the Novo Nordisk Foundation has invested quite heavily is in cell therapy, especially stem cell research.
News After setback, Rhythm gets good news on Imcivree from FDA Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.